Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Clinical Trials Open to More Cancer Patients With FDA Guidance

March 12, 2019, 5:17 PM

More cancer patients will be able to access experimental cutting-edge therapies under a new FDA policy to open the door to those who have historically been left out of clinical trials.

The Food and Drug Administration released a set of five guidance documents March 12 that make clear HIV patients, adolescents, and other subpopulations of cancer patients shouldn’t automatically be left out of the clinical trials that determine whether an experimental treatment is safe and effective enough for FDA approval. Because it takes more than seven years to bring a new cancer drug to market, clinical trials are usually the ...